Balchem (NASDAQ:BCPC), trading on the Nasdaq under the ticker BCPC, is a global specialty chemicals and nutrition company. The firm develops, manufactures and markets performance ingredients and ingredient systems that address a wide range of industries, including human and animal nutrition, food and beverage protection, pharmaceuticals and personal care. Balchem’s portfolio is built around core technologies such as advanced chelation, microencapsulation and custom ultrafine powders.
The company’s Specialty Products segment offers chelated minerals and microencapsulation solutions designed to improve nutrient delivery, stability and shelf life. Its Human Nutrition & Health segment provides ingredients and application expertise for dietary supplements, medical foods and functional beverages. Balchem’s proprietary technologies are applied to enhance flavor, protect sensitive materials and ensure precise dosage in both food and pharmaceutical formulations.
Founded in 1967 as Baltimore Chemical Company, Balchem adopted its current name in 2010 to reflect its expanded global scope and product offerings. Headquartered in New Hampton, New York, the company operates manufacturing and research facilities across North America, Europe and Asia. Balchem’s global footprint enables it to serve multinational customers and comply with regional regulatory requirements.
Under the leadership of President and Chief Executive Officer Thomas F. Coughlin, Balchem emphasizes innovation, quality and sustainability. The company invests in ongoing research and development to address emerging nutritional trends and regulatory challenges, positioning itself as a partner for customers seeking advanced ingredient solutions worldwide.
